Organization Chart
Purchase report to unlock comprehensive profile
Access Company's Structure and Understand its Departments
Novartis AG was incorporated on February 29, 1996, under the laws of Switzerland as a stock corporation (“Aktiengesellschaft”) with an indefinite duration. On December 20, 1996, the predecessor companies, Ciba-Geigy AG and Sandoz AG merged into this new entity, creating Novartis. The company was domiciled in and governed by the laws of Switzerland. Novartis is a multinational group of companies specializing in the research, development, manufacturing, and marketing of a broad range of innovative pharmaceuticals and cost-saving generic medicines. Novartis AG, the Swiss holding company, owns, directly or indirectly, all of our significant operating companies.
| Company Name | Novartis AG |
|---|---|
| Industry | Pharmaceuticals |
| HQ Address | Basel, Switzerland |
| Revenue | $51.6 Billion [2021] |
| Employee Size | 110000 |
| Company Type | Public |
| Fiscal Year-End | December 31st |
| Website | www.novartis.com |
| Subsidiaries | Novartis, Novartis India Ltd., Advanced Accelerator Applications, Novartis Gene Therapies, Chinook Therapeutics, Inc., Hexal AG and More |
| Locations | Americas, Europe, the Middle East, Africa, and Asia-Pacific |
| Competitors | Pfizer, GlaxoSmithKline, AstraZeneca, Merck & Co. |
| Recognition & Awards | Novartis was included in Fortune’s World’s Most Admired Companies list -2022 |
Access Company's Structure and Understand its Departments
Get Access to Company's Performance and Make Informed Decisions
Get Key Executives Contact to Enhance your Sales Strategy
Understand Company's Partners and Identify Potential Areas for Collaboration
Identify Company's Key Rivals for Competitive Edge
Gain Insight into Technology Partners and Access Exclusive Information on Key Tech Partners
Explore Customer Review to Understand its Service and Pinpoints
Analyse Company Strategies to Gain Market Insights and Stay Ahead of Your Competitors